Richard A. Paulson - 04 Feb 2025 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Signature
/s/Nancy Smith as Attorney-in-Fact for Richard Paulson
Issuer symbol
KPTI
Transactions as of
04 Feb 2025
Net transactions value
-$2,664
Form type
4
Filing time
05 Feb 2025, 16:16:21 UTC
Previous filing
07 Jan 2025
Next filing
04 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale $2,664 -4,099 -0.36% $0.6500 1,120,158 04 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.